top of page
SciSparc
Develops cannabinoid-based pharmaceuticals targeting central nervous system disorders, aiming to improve treatment outcomes for conditions like Tourette syndrome, epilepsy, and cognitive impairments.
Company Name | Neurotech Category | Market Category | Company Founded Year | Company Location |
|---|---|---|---|---|
SciSparc | NeuroPharmacology | NeuroBioTechnology | Biotechnology & Biopharmaceutical | 2004 | Givatayim |
Develops cannabinoid-based pharmaceuticals targeting central nervous system disorders, aiming to improve treatment outcomes for conditions like Tourette syndrome, epilepsy, and cognitive impairments.
bottom of page